# LLM Judge Evaluation: tier1_004

## Overall: PASS

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 2/2
- **Total**: 4/6

### Reasoning:
Completion: The trace shows the descriptors and macroscopic pKa workflows were submitted, reached “COMPLETED_OK,” results were retrieved, and the agent interpreted them. So completion is full.

Correctness: I validated the most decision-critical properties for CNS developability (pKa and logP). Literature pKa values for psilocybin are ≈1.3, 6.5, and 10.4 (phosphate1, phosphate2, amine), and the agent’s pKa1 is off by ~1.95 units. For logP, DrugBank lists predicted values of 1.25 (ALOGPS) and −0.14 (ChemAxon), indicating uncertainty; using 1.25 gives a 0.49-unit deviation from the agent’s 1.74. Given the rubric thresholds (pKa >1.5 units off → 0/2; logP error >0.3 → not full credit), overall correctness is poor.

Tool use: The agent used an appropriate sequence (SMILES lookup → descriptor/pKa workflows → status checks → retrieval), with valid inputs and successful runs. No critical tool failures, so full credit.

### Feedback:
- The computational workflows ran cleanly—nice job orchestrating lookup → submission → polling → retrieval.
- However, the macroscopic pKa estimates deviate notably from literature (especially pKa1). For phosphorylated tryptamines, ensure the phosphate acidities are captured (consider tautomer/protomer enumeration and explicit treatment of phosphate microstates). Cross-check with curated references before reporting.
- Your reported logP (1.74) conflicts with common predictions (1.25 ALOGPS; −0.14 ChemAxon). Given the zwitterionic form at pH 7.4, emphasize logD7.4 with clear provenance; verify against multiple calculators and, when possible, experimental logD.
- TPSA and HBA/HBD counts differed from common predictions; specify the algorithm (Ertl vs. fragment-based) and ionization state used. Reporting both neutral and dominant pH 7.4 microstate descriptors would improve relevance for CNS developability.
- Literature validation: Property: pKa1 (first phosphate)
- Agent value: 3.25
- Literature value: 1.3 (estimated for first phosphate OH)
- Source: Wikipedia Psilocybin page (values 1.3, 6.5, 10.4), which cites crystallographic/chemistry sources. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Psilocybin))
- Absolute error: |3.25 − 1.3| = 1.95
- Percent error: 1.95/1.3 × 100% ≈ 150%
- Score justification: Error >1.5 pKa units → fails threshold.

Property: pKa2 (second phosphate)
- Agent value: 5.59
- Literature value: 6.5
- Source: Wikipedia Psilocybin. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Psilocybin))
- Absolute error: |5.59 − 6.5| = 0.91
- Percent error: 0.91/6.5 × 100% ≈ 14%
- Score justification: 0.5–1.5 units off → outside full-credit tolerance.

Property: pKa3 (dimethylammonium)
- Agent value: 9.87
- Literature value: 10.4
- Source: Wikipedia Psilocybin. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Psilocybin))
- Absolute error: |9.87 − 10.4| = 0.53
- Percent error: 0.53/10.4 × 100% ≈ 5.1%
- Score justification: Slightly worse than ±0.5 unit cutoff; within ~10% but not within absolute-unit threshold.

Property: logP
- Agent value: 1.74
- Literature value: 1.25 (predicted, ALOGPS)
- Source: DrugBank DB11664 “Predicted Properties” (lists logP 1.25 by ALOGPS and −0.14 by ChemAxon). ([go.drugbank.com](https://go.drugbank.com/drugs/DB11664?utm_source=openai))
- Absolute error: |1.74 − 1.25| = 0.49
- Percent error: 0.49/1.25 × 100% ≈ 39.2%
- Score justification: Deviation >0.3 units → not within full-credit tolerance; also note cross-method variability (Chemaxon −0.14) underscores uncertainty. ([go.drugbank.com](https://go.drugbank.com/drugs/DB11664?utm_source=openai))

Additional cross-check (context only, not scored):
- Molecular weight: Agent 284.09 g/mol vs. literature 284.25 g/mol (C12H17N2O4P). Abs error 0.16 g/mol (0.06%). Source: ChemicalBook. ([chemicalbook.com](https://www.chemicalbook.com/ChemicalProductProperty_EN_CB5932766.htm?utm_source=openai))

### Web Search Citations:
1. [Psilocybin - Wikipedia](https://en.wikipedia.org/wiki/Psilocybin)
2. [Psilocybin - Wikipedia](https://en.wikipedia.org/wiki/Psilocybin)
3. [Psilocybin - Wikipedia](https://en.wikipedia.org/wiki/Psilocybin)
4. [Psilocybin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB11664?utm_source=openai)
5. [Psilocybin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB11664?utm_source=openai)
6. [psilocybine | 520-52-5](https://www.chemicalbook.com/ChemicalProductProperty_EN_CB5932766.htm?utm_source=openai)

### Execution:
- **Tools**: workflow_get_status, submit_macropka_workflow, molecule_lookup, retrieve_workflow, submit_descriptors_workflow
- **Time**: 67.4 min

---
*Evaluated with openai/gpt-5*
